All Clinical Trials

A listing of 23115 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Trials

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Healthy Participants Needed (Colonoscopy + Cancer Screening)

Recruiting

Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.

Conditions:

Healthy

Healthy Volunteers

Healthy Subjects

Healthy Volunteer

Healthy Participants

Learn More

Featured Trial

Buy Retatrutide Online Through Celia

Recruiting

Retatrutide (formerly M25) is an investigational peptide being studied for its potential in supporting weight management and metabolic health. It acts on GLP-1, GIP, and glucagon receptors to influence appetite, energy regulation, and fat metabolism.

Conditions:

Healthy

Learn More

Featured Offer

Lose 20% of Body Weight With GLP-1's

Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to tirzepatide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

Semaglutide and Tirzepatide are advanced GLP-1 medications designed to support weight management and metabolic health. They work by targeting GLP-1 receptors in the body, helping regulate appetite, improve blood sugar control, and support sustainable weight loss (up to 22% of body weight).

Get $50 off your first order using promo code: policy-lab-50

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

Featured Trial

Birth Control Clinical Research Study

Recruiting

Living with obesity and looking for a birth control option that is right for you? Clinical trials are now enrolling women with a body mass index (BMI) of 30 or more in the area to help study a potential new progestin-only contraceptive patch. Participating in research studies can help advance birth control options. Don’t let financial stress hold you back. All study-related assessments, care, and study patch are available at no cost. You may also be reimbursed for study-related travel.

Conditions:

Obesity

Overweight

Overweight and Obesity

Learn More

Featured Trial

Depression Clinical Trial

Recruiting

Join us in researching a potential investigational treatment for Depression. Reimbursement for study-related expenses may be available to you.

Qualifying participants:
•Are between 18-65
•Have been experiencing a major depressive episode for at least a month

Conditions:

Depression

Major Depressive Disorder

Depressive Disorder

Depressive Symptoms

Depressive Disorder

Learn More

Featured Offer

Ketamine Therapy—At Home, Clinician-Guided (Innerwell)

If you’re exploring options besides a clinical trial, Innerwell provides at-home ketamine therapy with medical oversight and structured support. Ketamine-assisted treatment may help “reset” rigid stress and mood patterns, and some people feel relief within a few sessions. Your care team works with you to tailor treatment and track progress every step of the way. Proven effective for Anxiety, PTSD, Depression, Addiction, and other disease areas.

Conditions:

Anxiety

Anxiety Disorders

Generalized Anxiety Disorder

Depression

Learn More

Providing an Optimized and Empowered Pregnancy for You (POPPY) Aim 3: Randomized Controlled Trial

NCT06510075

Recruiting

The PᵌOPPY study is designed to support the American Heart Association's mission to improve maternal/infant health outcomes and address inequities in maternal/infant health care. The P3OPPY Project is one of five projects within the American Heart Association P3 EQUATE Network. The overarching goal of the P3 EQUATE American Heart Association Health Equity Research Network (HERN) is to promote equity in Maternal and Infant Health outcomes by identifying innovative and cost-effective strategies to... Read More

Gender:

FEMALE

Ages:

Between 16 years and 49 years

Trial Updated:

08/13/2025

Locations: University of Alabama at Birmingham, Birmingham, Alabama

Conditions: Pregnancy Complications, Maternal Distress, Adverse Birth Outcomes, Infant Conditions

Learn More ›

Rapid Response of Stem Cells and Immune Cells for Efficacy

NCT07127705

Recruiting

The goal for this clinical trial is to compare rapid effects of four products on stem cells, immune activation, and mitochondrial function. A double-blind, placebo-controlled, cross-over study design will be used.

Gender:

ALL

Ages:

Between 18 years and 75 years

Trial Updated:

08/13/2025

Locations: NIS Labs, Klamath Falls, Oregon

Conditions: Stem Cell Surveillance

Learn More ›

Comparing Integrative Interventions for Chronic Pelvic Pain

NCT07066345

Recruiting

The researchers will conduct a pilot randomized trial to assess functional changes with two different remote integrative non-pharmacologic interventions for women with chronic pelvic pain (CPP). The study team will compare a novel web-based, cognitive-behavioral program designed for patients with CPP and a commercially available physical activity remote application. The team aims to gather information about differences in sexual function, physical function, pain, and quality of life.

Gender:

FEMALE

Ages:

Between 18 years and 55 years

Trial Updated:

08/13/2025

Locations: University of Michigan, Ann Arbor, Michigan

Conditions: Pelvic Pain

Learn More ›

Retrograde Versus Antegrade Perfusion in Low-Moderate Hypothermia for Aortic Arch Surgery

NCT06986967

Recruiting

The purpose of this study is to compare brain function after surgical circulatory arrest using either antegrade perfusion or retrograde perfusion.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/13/2025

Locations: Duke Univeristy, Durham, North Carolina +1 locations

Conditions: Brain Function, Hemiarch Cardiac Procedure

Learn More ›

Task Practice and Spinal Cord Stimulation

NCT06494020

Recruiting

The goal of this study is to understand the effects of combined task practice with transcutaneous cervical spinal cord stimulation. The study will explore the effect of higher stimulation frequencies on spasticity. Transcutaneous stimulation has been shown to improve motor function in some individuals with chronic spinal cord injury. The study intends to explore scientifically the association between higher stimulation frequencies and spasticity/hypertonicity.

Gender:

ALL

Ages:

Between 22 years and 70 years

Trial Updated:

08/13/2025

Locations: University of Miami - Christine E. Lynn Rehabilitation Center, Miami, Florida +1 locations

Conditions: Spinal Cord Injury Cervical, Spastic

Learn More ›

Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming

NCT06536881

Recruiting

This research is being done to test the feasibility of 24-48 hours of water-only fasting to improve delivery of 4 cycles of chemotherapy in those receiving breast cancer treatment either before or after surgery.

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

08/13/2025

Locations: Sibley Memorial Hospital, Washington, District of Columbia

Conditions: Breast Cancer, Early-stage Breast Cancer

Learn More ›

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

NCT07094204

Recruiting

Genes contain genetic code which tell the body which proteins to make. Many types of cancer are caused by changes, or mutations, in a gene called KRAS. Researchers are looking for ways to stop the actions of abnormal proteins made from the mutated KRAS gene. ASP5834 is being studied in people with solid tumors who have certain KRAS gene mutations. Some people with solid tumors of the colon or rectum (colorectal cancer), will be given ASP5834 with panitumumab. Panitumumab is a treatment for colorectal cancer. In this study, the researchers will learn how ASP5834 is processed by and acts upon the body. This information will help find a suitable dose of ASP5834 and check for any potential medical problems from the treatment. The main aims of this study are to check the safety of ASP5834 given by itself or given with panitumumab, and how well it is tolerated; and to find a suitable dose of ASP5834 given by itself or given with panitumumab. People in this study will be adults with locally advanced, unresectable, or metastatic solid tumors with certain KRAS gene mutations. Locally advanced means the cancer has spread to nearby tissue. Unresectable means the cancer cannot be removed by surgery. Metastatic means the cancer has spread to other parts of the body. The key reasons people cannot take part are if they have specific uncontrollable cancers such as symptomatic or untreated cancers in nervous system, or have a specific heart condition, or infections. In this study, ASP5834 is being given to humans for the first time. This is an open-label study. This means that people in this study and clinic staff will know that they will receive ASP5834 by itself or ASP5834 with panitumumab. This study will be in 2 parts: Part 1 is called Dose Escalation. Different small groups of people will receive lower to higher doses of either: ASP5834 by itself or ASP5834 with panitumumab. Only people who have colorectal cancer will receive ASP5834 with panitumumab. People with any type of solid tumor will receive ASP5834 by itself. For each dose, all medical problems will be recorded. A medical expert panel will check the results and decide if the next group can receive a higher dose of ASP5834. The panel will do this until the planned maximum number of people are treated or until suitable doses have been selected for Part 2. Part 2 is called Dose Expansion. Other different small groups of people will receive ASP5834 or ASP5834 with panitumumab. They will receive the most suitable doses worked out from Part 1. In both parts of the study, the study treatments ASP5834 and panitumumab will be given through a vein. This is called an infusion. Each study treatment cycle is either 21 days or 28 days long. People will continue study treatment until: they have medical problems from the study treatment they can't tolerate; their cancer gets worse; they start other cancer treatment; or they ask to stop study treatment. People will visit the clinic on certain days during their study treatment, with extra visits during the first 2 cycles of study treatment. The study doctors will check for any medical problems from ASP5834. Also, people in the study will have a health check. On some visits they will also have scans to check for any changes in their cancer. Tumor samples will be taken at certain visits during study treatment with the option of a tumor sample being taken if people's cancer gets worse or the cancer comes back. People will visit the clinic shortly after stopping treatment for a health check. After this, people will have health checks every couple of months to check the condition of their cancer. The number of visits and checks done will depend on the health of each person and whether they completed their study treatment or not. It is expected that people will be in this study for about 1 year. Read Less

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/13/2025

Locations: START Midwest, Grand Rapids, Michigan +2 locations

Conditions: Solid Tumor, Non-Small-Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma, Colorectal Cancer

Learn More ›

SIMPLAAFY Clinical Trial

NCT06521463

Recruiting

The primary objective is to demonstrate the safety and effectiveness of two monotherapy regimens versus dual antiplatelet (DAPT) therapy following post-implant with the WATCHMAN FLX Pro device in a commercial clinical setting.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/13/2025

Locations: University of Alabama Birmingham, Birmingham, Alabama +77 locations

University of Alabama Birmingham, Birmingham, Alabama

Grandview Medical Center, Birmingham, Alabama

Phoenix Cardiovascular Research Group, Phoenix, Arizona

HonorHealth Heart Group - Shea, Scottsdale, Arizona

Tucson Medical Center Healthcare, Tucson, Arizona

Arrhythmia Research Group, Jonesboro, Arkansas

Mills Peninsula Health Services, Burlingame, California

John Muir Medical Center, Concord, California

Scripps Memorial Hospital, La Jolla, California

Loma Linda University Medical Center, Loma Linda, California

Santa Barbara Cottage Hospital, Santa Barbara, California

Los Robles Hospital & Medical Center, Thousand Oaks, California

Cardiology Associates Medical Group, Ventura, California

Colorado Heart and Vascular PC, Lakewood, Colorado

Medical Center of the Rockies, Loveland, Colorado

Hartford Hospital, Hartford, Connecticut

Washington Hospital, Washington, District of Columbia

Baptist Medical Center, Jacksonville, Florida

HCA Florida Mercy Hospital, Miami, Florida

Naples Community Hospital, Naples, Florida

Sarasota Memorial Hospital, Sarasota, Florida

Emory University Hospital, Atlanta, Georgia

Georgia Arrhythmia Consultants, Macon, Georgia

Wellstar Kennestone Hospital, Marietta, Georgia

Memorial Health University Medical Center, Savannah, Georgia

St. Luke's Boise Medical Center, Boise, Idaho

Evanston Hospital, Evanston, Illinois

Midwest Cardiovascular Institute, Naperville, Illinois

Advocate Christ Medical Center, Oak Lawn, Illinois

Community Heart and Vascular Hospita, Indianapolis, Indiana

Mercy Hospital Medical Center, Des Moines, Iowa

University of Kansas, Kansas City, Kansas

Baptist Health Lexington, Lexington, Kentucky

Norton Hospital, Louisville, Kentucky

Massachusetts General Hospital, Boston, Massachusetts

Charlton Memorial, Fall River, Massachusetts

University of Massachusetts Memorial Medical Center, Worcester, Massachusetts

St. Joseph Mercy Hospital, Ann Arbor, Michigan

Henry Ford Hospital, Detroit, Michigan

Corewell Health, Grand Rapids, Michigan

M Health Fairview St John's Hospital, Maplewood, Minnesota

Mayo Clinic Foundation, Rochester, Minnesota

Centracare Heart and Vascular Center, Saint Cloud, Minnesota

University of Mississippi Medical Center, Jackson, Mississippi

North Mississippi Medical Center, Tupelo, Mississippi

St. Luke's Hospital of Kansas City, Kansas City, Missouri

Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire

Virtua Health, Marlton, New Jersey

Valley Hospital, Paramus, New Jersey

Lovelace Medical Center, Albuquerque, New Mexico

Kaleida Health, Buffalo, New York

New York University Medical Center, New York, New York

Mount Sinai Medical Center, New York, New York

Carolinas Medical Center, Charlotte, North Carolina

Novant Health Presbyterian Medical Center, Charlotte, North Carolina

Rex Hospital, Raleigh, North Carolina

Wake Medical Center, Raleigh, North Carolina

Bethesda North Hospital-Hospital, Cincinnati, Ohio

University Hospitals of Cleveland, Cleveland, Ohio

Ohio State University Medical Center, Columbus, Ohio

Legacy Emanuel Hospital & Health Center, Portland, Oregon

Pinnacle Health at Harrisburg Hospital, Harrisburg, Pennsylvania

Trident Medical Center, Charleston, South Carolina

Prisma Health, Columbia, South Carolina

Stern Cardiovascular Foundation, Germantown, Tennessee

St. Thomas Heart, Nashville, Tennessee

Texas Cardiac Arrhythmia Research, Austin, Texas

Memorial Hermann Memorial City Medical Center, Houston, Texas

Methodist Hospital, San Antonio, Texas

Christus Trinity Mother Frances Health System-Hospital, Tyler, Texas

St. Mark's Hospital, Salt Lake City, Utah

Sentara Norfolk General Hospital, Norfolk, Virginia

Chippenham & Johnston-Willis Hospital, Richmond, Virginia

Carilion Roanoke Memorial Hospital, Roanoke, Virginia

Overlake Hospital Medical Center, Bellevue, Washington

Monongalia General Hospital, Morgantown, West Virginia

Bellin Health, Green Bay, Wisconsin

Froedtert Memorial Lutheran Hospital, Milwaukee, Wisconsin

Conditions: Atrial Fibrillation, Stroke, Bleeding

Learn More ›

Breathwork Intervention for Posttraumatic Stress

NCT07129278

Recruiting

The goal of this single-site, single-arm pilot study is to examine the impact of breathwork training for posttraumatic stress symptoms in an adult veteran population. Participants will complete a single, in-person breathwork session (2 hours) led by a certified breathwork facilitator and engage in an integration session (30 minute) with a licensed psychologist. Participants will be invited to engage in two, optional, virtual follow up breathwork sessions (40 minute practice each) during weeks 2... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/13/2025

Locations: Diamond Rose Sanctuary, Branford, Connecticut +1 locations

Conditions: PTSD

Learn More ›

Methamphetamine and Troriluzole

NCT06989853

Recruiting

This will be a human laboratory study evaluating the influence of troriluzole treatment on the effects of methamphetamine. Supported by and included in the Helping to End Addiction Long-term® (HEAL) Initiative.

Gender:

ALL

Ages:

Between 18 years and 55 years

Trial Updated:

08/13/2025

Locations: Psychopharmacology of Addiction Laboratory, Lexington, Kentucky

Conditions: Methamphetamine Use Disorder

Learn More ›

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

NCT06623422

Recruiting

The goal of this study is to learn if people who receive intismeran autogene and pembrolizumab after surgery are cancer-free longer than people who receive placebo and pembrolizumab. Researchers want to know if giving intismeran autogene and pembrolizumab after surgery can help prevent the cancer from coming back in people with non-small cell lung cancer (NSCLC) whose tumors did not respond completely to treatment before surgery (neoadjuvant treatment).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/13/2025

Locations: Banner MD Anderson Cancer Center ( Site 0181), Gilbert, Arizona +155 locations

Banner MD Anderson Cancer Center ( Site 0181), Gilbert, Arizona

Providence St. Jude Medical Center ( Site 0106), Fullerton, California

UCSF Medical Center at Mission Bay ( Site 0178), San Francisco, California

UCHealth Memorial Hospital Central ( Site 0125), Colorado Springs, Colorado

Banner MD Anderson Cancer Center at North Colorado Medical Center ( Site 0207), Greeley, Colorado

Beacon Cancer Care ( Site 0127), Post Falls, Idaho

The University of Chicago Medical Center ( Site 0118), Chicago, Illinois

Massachusetts General Hospital ( Site 0136), Boston, Massachusetts

Dana Farber Cancer Hospital ( Site 0155), Boston, Massachusetts

Ellis Fischel Cancer Center ( Site 0133), Columbia, Missouri

Lake Regional Hospital-Cancer Center ( Site 0123), Osage Beach, Missouri

Montefiore Medical Center ( Site 0160), Bronx, New York

Roswell Park Cancer Institute ( Site 0184), Buffalo, New York

Hematology-Oncology Associates of CNY ( Site 0164), East Syracuse, New York

Icahn School of Medicine at Mount Sinai ( Site 0116), New York, New York

Memorial Sloan Kettering Cancer Center ( Site 0137), New York, New York

SUNY Upstate Cancer Center ( Site 0140), Syracuse, New York

Westchester Medical Center ( Site 0196), Valhalla, New York

University of Cincinnati Medical Center ( Site 0119), Cincinnati, Ohio

St. Lukes Hospital and Health Network ( Site 0186), Bethlehem, Pennsylvania

Thompson Cancer Survival Center ( Site 0168), Knoxville, Tennessee

MD Anderson Cancer Center ( Site 0150), Houston, Texas

Memorial Hermann Cancer Center ( Site 0172), Houston, Texas

O'Quinn Medical Tower at McNair Campus ( Site 0131), Houston, Texas

The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center ( Site 0148), Tyler, Texas

Swedish Cancer Institute ( Site 0143), Seattle, Washington

Virginia Mason Franciscan Health - St. Michael Cancer Center ( Site 0192), Silverdale, Washington

CEMIC ( Site 2454), Caba., Buenos Aires

Fundacion Intecnus ( Site 2456), San Carlos de Bariloche, Rio Negro

Centro Médico IPAM ( Site 2452), Rosario, Santa Fe

Instituto Medico Especializado Alexander Fleming ( Site 2457), Buenos Aires, Not set

Instituto Oncologico de Cordoba -IONC ( Site 2455), Cordoba, Not set

Calvary Mater Newcastle ( Site 2106), Waratah, New South Wales

Tasman Oncology Research ( Site 2104), Southport, Queensland

Princess Alexandra Hospital ( Site 2102), Wooloongabba, Queensland

Grampians Health ( Site 2101), Ballarat, Victoria

One Clinical Research ( Site 2103), Nedlands, Western Australia

Cliniques Universitaires Saint-Luc ( Site 1203), Bruxelles, Bruxelles-Capitale, Region De

Jessa Ziekenhuis ( Site 1204), Hasselt, Limburg

UZ Gent ( Site 1201), Gent, Oost-Vlaanderen

CRIO - CENTRO REGIONAL INTEGRADO DE ONCOLOGIA ( Site 2502), Fortaleza, Ceara

Liga Norte Riograndense Contra o Cancer ( Site 2513), Natal, Rio Grande Do Norte

Hospital Tacchini ( Site 2506), Bento Goncalves, Rio Grande Do Sul

Hospital de Clínicas de Passo Fundo ( Site 2504), Passo Fundo, Rio Grande Do Sul

Hospital Moinhos de Vento ( Site 2510), Porto Alegre, Rio Grande Do Sul

Hospital Nossa Senhora Da Conceicao ( Site 2512), Porto Alegre, Rio Grande Do Sul

Instituto de Oncologia Saint Gallen ( Site 2507), Santa Cruz do Sul, Rio Grande Do Sul

Hospital de Amor - Barretos ( Site 2511), Barretos, Sao Paulo

Instituto Nacional de Câncer - INCA ( Site 2501), Rio de Janeiro, Not set

MBAL Uni Hospital ( Site 1253), Panagyurishte, Pazardzhik

MHAT - Heart and Brain ( Site 1252), Pleven, Not set

Queen Elizabeth II Health Sciences Centre ( Site 1101), Halifax, Nova Scotia

Hamilton Health Sciences - Juravinski Site ( Site 1104), Hamilton, Ontario

Kingston Health Sciences Centre-Kingston General Hospital Site ( Site 1105), Kingston, Ontario

Lakeridge Health ( Site 1107), Oshawa, Ontario

McGill University Health Centre ( Site 1103), Montréal, Quebec

IUCPQ ( Site 1112), Québec, Quebec

FALP ( Site 2551), Santiago., Region M. De Santiago

Orlandi Oncologia ( Site 2555), Santiago, Region M. De Santiago

Clínica RedSalud Vitacura ( Site 2556), Santiago, Region M. De Santiago

Bradfordhill ( Site 2552), Santiago, Region M. De Santiago

ONCOCENTRO APYS ( Site 2554), Viña del Mar, Valparaiso

IMAT S.A.S ( Site 2602), Monteria, Cordoba

FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 2603), Bogota, Distrito Capital De Bogota

Hospital Universitario San Ignacio ( Site 2610), Bogota, Distrito Capital De Bogota

Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia ( Site 2604), Bogota, Distrito Capital De Bogota

Oncologos del Occidente ( Site 2608), Pereira, Risaralda

Fundacion Valle del Lili- CIC ( Site 2601), Cali, Valle Del Cauca

Oulun yliopistollinen sairaala ( Site 1301), Oulu, Pohjois-Pohjanmaa

Turku University Hospital ( Site 1303), Turku, Varsinais-Suomi

CHU Besançon ( Site 1358), Besancon, Franche-Comte

Institut De Cancerologie De L Ouest ( Site 1357), Saint Herblain, Loire-Atlantique

CENTRE LEON BERARD ( Site 1351), Lyon CEDEX 08, Rhone

Marienhaus Klinikum Mainz ( Site 1403), Mainz, Rheinland-Pfalz

UNIVERSITY HOSPITAL OF PATRAS-DIVISION OF ONCOLOGY ( Site 1452), Patras, Achaia

Errikos Dunant Hospital Center ( Site 1457), Athens, Attiki

THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA"-3rd Dept of Internal Medicine and Laboratory, Oncol ( Site 1451), Athens, Attiki

Metropolitan Hospital ( Site 1459), Athens, Attiki

ATTIKON GENERAL UNIVERSITY HOSPITAL ( Site 1460), Chaidari, Attiki

University General Hospital of Herakleion ( Site 1458), Herakleion., Irakleio

University General Hospital of Larissa-Oncology Clinic ( Site 1453), Larissa, Thessalia

Papageorgiou General Hospital of Thessaloniki ( Site 1454), Thessaloniki, Not set

Petz Aladár Megyei Oktató Kórház ( Site 1502), Gyor, Gyor-Moson-Sopron

Debreceni Egyetem Altalanos Orvostudomanyi Kar Tudogyogyaszati Tanszek ( Site 1508), Debrecen, Hajdu-Bihar

Mátrai Gyógyintézet ( Site 1504), Mátraháza, Heves

Reformatus Pulmonologiai Centrum-Onkopulmonologiai Jarobeteg Centrum ( Site 1505), Törökbálint, Pest

Somogy Vármegyei Kaposi Mór Oktató Kórház-Oncology center ( Site 1507), Kaposvár, Somogy

Orszagos Koranyi Pulmonologiai Intezet ( Site 1501), Budapest, Not set

Rambam Health Care Campus ( Site 1603), Haifa, Not set

Shaare Zedek Medical Center ( Site 1601), Jerusalem, Not set

Hadassah Medical Center ( Site 1605), Jerusalem, Not set

Sheba Medical Center ( Site 1602), Ramat Gan, Not set

Hospital of the University of Occupational and Environmental Health, Japan ( Site 1166), Kitakyushu, Fukuoka

St. Marianna University Hospital ( Site 1159), Kawasaki, Kanagawa

Kindai University Hospital ( Site 1162), Osakasayama, Osaka

Shizuoka Cancer Center ( Site 1160), Sunto-gun, Shizuoka

National Cancer Center Hospital ( Site 1156), Chuo, Tokyo

Tokyo Medical University Hospital ( Site 1157), Shinjuku, Tokyo

Chiba University Hospital ( Site 1154), Chiba, Not set

National Hospital Organization Kyushu Cancer Center ( Site 1167), Fukuoka, Not set

Fukushima Medical University Hospital ( Site 1151), Fukushima, Not set

Hiroshima University Hospital ( Site 1165), Hiroshima, Not set

Okayama University Hospital ( Site 1164), Okayama, Not set

Wakayama Medical University Hospital ( Site 1163), Wakayama, Not set

National Cancer Center ( Site 2305), Goyang-si, Kyonggi-do

The Catholic University of Korea St. Vincent s Hospital ( Site 2301), Suwonsi, Kyonggi-do

Ajou University Hospital ( Site 2306), Suwon, Kyonggi-do

Seoul National University Hospital ( Site 2303), Seoul, Not set

Severance Hospital Yonsei University Health System ( Site 2302), Seoul, Not set

Samsung Medical Center ( Site 2304), Seoul, Not set

Seoul St. Mary's Hospital ( Site 2307), Seoul, Not set

Medisch Centrum Leeuwarden ( Site 1702), Leeuwarden, Fryslan

Radboudumc ( Site 1706), Nijmegen, Gelderland

Dunedin Hospital ( Site 2202), Dunedin, Otago

Aliada ( Site 2753), Lima, Not set

Detecta Clínica ( Site 2751), Lima, Not set

Krakowski Szpital Specjalistyczny im. Jana Pawla II ( Site 1756), Krakow, Malopolskie

Instytut Gruźlicy i Chorób Płuc w Warszawie ( Site 1764), Warszawa, Mazowieckie

Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 1759), Przemysl, Podkarpackie

Uniwersyteckie Centrum Kliniczne ( Site 1758), Gdansk, Pomorskie

Swietokrzyskie Centrum Onkologii. ( Site 1754), Kielce, Swietokrzyskie

Warmińsko - Mazurskie Centrum Chorób Płuc w Olsztynie ( Site 1760), Olsztyn, Warminsko-mazurskie

Wielkopolskie Centrum Pulmonologii i Torakochirurgii ( Site 1763), Poznan, Wielkopolskie

Centrul Medical Medicover Victoria ( Site 1802), Bucharest, Bucuresti

Institutul Regional de Oncologie ( Site 1804), Iasi, Not set

National Cancer Centre Singapore ( Site 2251), Singapore, Central Singapore

Tan Tock Seng Hospital ( Site 2252), Singapore, Central Singapore

Hospital Clinic de Barcelona ( Site 1919), Barcelona, Cataluna

Complejo Hospitalario Universitario A Coruna ( Site 1916), A Coruña, La Coruna

Hospital Universitario Quiron Madrid ( Site 1913), Pozuelo de Alarcon, Madrid

Hospital Universitari Vall D Hebron ( Site 1910), Barcelona, Not set

Hospital Insular de Gran Canaria ( Site 1911), Canarias, Not set

Hospital General Universitario Gregorio Maranon ( Site 1912), Madrid, Not set

Hospital Quiron Malaga ( Site 1914), Malaga, Not set

Karolinska Universitetssjukhuset Solna ( Site 1951), Stockholm, Stockholms Lan

Chung Shan Medical University Hospital ( Site 2351), Taichung, Not set

China Medical University Hospital ( Site 2358), Taichung, Not set

National Cheng Kung University Hospital ( Site 2354), Tainan, Not set

National Taiwan University Cancer Center (NTUCC) ( Site 2360), Taipei, Not set

Mackay Memorial Hospital ( Site 2355), Taipei, Not set

Taipei Medical University Hospital ( Site 2352), Taipei, Not set

Koo Foundation Sun Yat-Sen Cancer Center ( Site 2359), Taipei, Not set

Taipei Veterans General Hospital ( Site 2357), Taipei, Not set

Chang Gung Memorial Hospital ( Site 2361), Taoyuan, Not set

Hacettepe Universite Hastaneleri ( Site 2001), Sıhhiye, Ankara

Sakarya Universitesi Tip Fakultesi Hastanesi ( Site 2006), Adapazarı, Sakarya

Namık Kemal University Medical Faculty ( Site 2007), Tekirdag, Tekirdas

Ankara Bilkent Sehir Hastanesi ( Site 2002), Ankara, Not set

TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi ( Site 2003), Istanbul, Not set

Bristol Haematology and Oncology Centre ( Site 2072), Bristol, Bristol, City Of

St Bartholomews Hospital ( Site 2052), London, London, City Of

Royal Free Hospital ( Site 2074), London, London, City Of

Guys Hospital ( Site 2057), London, London, City Of

Nottingham City Hospital ( Site 2058), Nottingham, Nottinghamshire

St James University Hospital ( Site 2055), Leeds, Not set

The Clatterbridge Cancer Centre ( Site 2069), Wirral, Not set

Conditions: Carcinoma, Non-Small-Cell Lung

Learn More ›

Home Blood Transfusions

NCT07121140

Recruiting

This is a pilot single arm study to evaluate the feasibility and acceptability of a home blood transfusion program. Patients will be enrolled with hematologic malignancies and other bone marrow failure syndromes who are transfusion dependent and interested in a home blood transfusion program. Participants enrolled in the study will receive 1-5 units of blood products at home. Data on barriers to administration will be recorded. Surveys and qualitative interviews will be completed to better under... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/12/2025

Locations: Thomas Jefferson University Hospital, Philadelphia, Pennsylvania

Conditions: Hematologic Malignancy, Myelodysplastic Syndromes, Acute Myeloid Leukemia, Transfusion Dependent Cytopenias

Learn More ›